Introduction
The MDM2 gene maps to chromosome 12q14.3-q15. 1 The MDM2 protein forms a complex with the p53 protein, attenuates the activity of p53, and promotes the subsequent degradation of p53 by acting as a ubiquitin E3 ligase for p53. 2, 3 The abnormal expression of the MDM2/TP53 genes is linked to carcinogenesis or malignant transformation. 2, 4, 5 Accumulating evidence supports the link between the alteration of protein structural/functional behavior and single-nucleotide polymorphisms (SNPs) within relative genes. [6] [7] [8] [9] [10] [11] Multiple prediction or detection techniques, such as structural biology, computational platform, and molecular dynamic simulation, contribute to the investigation of identification and function of disease-associated SNPs. [6] [7] [8] [9] [10] [11] The SNPs of rs2279744 (T309G or SNP309), rs3730485 (del1518 +/-) and rs937283 (A2164G), have been identified in the human MDM2 gene. 12, 13 Previous reports have shown that MDM2 polymorphisms are associated with susceptibility to various clinical diseases, such as bladder cancer,submit your manuscript | www.dovepress.com
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Yu et al Keratinization of the epidermal cells often leads to the occurrence of squamous cell carcinoma (SCC), which behaves as the uncontrolled growth of outer abnormal squamous cells of the epidermis. [19] [20] [21] Specific types of SCC, such as head and neck SCC (HNSCC), skin squamous cell carcinoma (SSCC), esophageal SCC (ESCC), oral SCC (OSCC), lung SCC (LSCC), and cervical squamous cell carcinoma (CSCC), have been described. [19] [20] [21] [22] [23] The different effects of the genetic mutations within MDM2 have been reported to be related to the carcinogenesis of specific SCC types. For example, a lower plasma MDM2 level was observed in laryngeal SCC patients with the GT genotype of MDM2 rs2279744 than the TT genotype. 24 The prevalence of MDM2 rs2279744 might be involved in OSCC onset, rather than increased OSCC risks. 25 Although several previous meta-analyses on the correlation between MDM2 rs2279744 polymorphism and the risks of HNSCC, OSCC, or ESCC have been reported, [26] [27] [28] another systematic evaluation with enlarged statistical power is still meaningful. Moreover, the meta-analyses of the association between MDM2 rs937283 and rs3730485 polymorphisms and SCC risks, or between the MDM2 rs2279744 polymorphism and other SCC types, such as SSCC and CSCC, have not been reported yet. It was thus worthwhile carrying out an updated systematic review and meta-analysis, in order to reassess the genetic relationship between common MDM2 polymorphisms (rs2279744, rs937283, and rs3730485) and the overall risks of SCC.
Materials and methods article search
We searched for potentially relevant articles (up to May 7, 2016 ) from seven electronic databases: PubMed, Web of Science, Cochrane, Scopus, Chinese National Knowledge Infrastructure (CNKI), Wanfang, and Weipu. The key terms were as follows: mouse double minute 2 homolog; proto-oncogene proteins c-mdm2; MDM2; MDM2 proto-oncogene, E3 ubiquitin protein ligase; human homolog of mouse double minute 2; murine double minute 2; polymorphism; mutation; SNP; single nucleotide polymorphism; T309G; rs2279744; A2164G; rs937283; del1518; rs3730485; G285C; rs117039649; squamous cell carcinoma; carcinoma, squamous cell; and SCC.
article screening and data extraction
With the help of EndNote X7 software, potential articles were screened for eligibility according to our strict inclusion/ exclusion criteria. Exclusion criteria were duplicated articles, review or conference abstract, not human or clinical data, not relevant to MDM2, not about SCC, meta-analysis, not relevant to mutation, lack of control data, and overlapped data. Eligible case-control studies needed to be linked to SCC risks and contain data on individual genotype numbers of MDM2 rs2279744, rs937283, and rs3730485 polymorphisms. We independently extracted the following data: first author, year of publication, country, ethnicity, SNPs, sample sizes and genotype frequencies of case/control group, SCC type, source of control, genotyping assay, P-values of Hardy-Weinberg equilibrium (HWE), and test of control groups. A detailed discussion was required for the conflicting assessment.
statistical analysis
Pooled odds ratios (ORs) with 95% confidence intervals (CIs) and P-values of associations based on Mantel-Haenszel statistics were calculated by Stata 12.0 software (StataCorp LP, College Station, TX, USA). P.0.05 was considered the exclusion of statistically significant difference between case and control groups. The I 2 test (0%-100%) and Q-statistic were adopted to evaluate the potential heterogeneities across casecontrol studies. I 2 .25% or P-value of Q-statistic ,0.1 was considered significant heterogeneity, and statistical analysis under a random-effect model and sensitivity analysis were conducted. Six genetic (allele, homozygote, heterozygote, dominant, recessive, and carrier) models were employed. Subgroup analyses by ethnicity, source of controls, HWE or SCC types were also performed. In addition, potential publication bias was assessed by analysis of Begg's funnel plots (continuity-corrected) and Egger's publication-bias plots. Figure 1 shows a flow diagram of our article-search strategy. A total of 545 potentially relevant articles were retrieved initially from the databases: PubMed (n=95), Web of Science (n=260), Cochrane (n=0), Scopus (n=73), CNKI (n=54), Wanfang (N=44), and Weipu (n=19). A total of 378 articles were obtained after duplicates had been removed by the EndNote software, and then 336 articles were excluded by screening titles and abstracts according to the exclusion criteria. Specific information is shown in Figure 1 . Next, 42 full-text articles were assessed for eligibility; 16 articles were then excluded for lack of control data (n=10) and overlapped data (n=6). Finally, 26 independent articles with 7,987 SCC cases and 12,954 controls were selected for our meta-analysis. 4, 12, 13, 18, 24, 25, [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] We then carefully extracted the data and summarized the characteristics (Table 1) .
Results
Studies selected for meta-analysis
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Polymorphism rs2279744 of MDM2 and scc susceptibility
A total of 25 case-control studies 4, 12, 13, 18, 24, 25, [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] were enrolled for the meta-analysis of MDM2 rs2279744 and risks of SCC. As shown in Table 2 (Figure 2A ), homozygote ( Figure 3A) , heterozygote ( Figure 4A ), dominant ( Figure 5A ), and recessive ( Figure 6A ) models. These data revealed that the GG genotype of MDM2 rs2279744 was statistically associated with increased SCC susceptibility.
Furthermore, subgroup analyses by ethnicity (Asian/ Caucasian), HWE (P.0.05/P,0.05), source of control (population-based/hospital-based), and SCC type (HNSCC/ SSCC/ESCC/OSCC/CSCC/LSCC) were performed for all genetic models. As shown in Table 3 
Polymorphisms rs937283 and rs3730485 of MDM2 and scc susceptibility
Next, pooled analysis for the association between the rs937283 and rs3730485 polymorphisms of MDM2 and the risks of SCC was conducted (Table 2) . A random-effect model was used for the comparison of G vs A, GG vs AA, AG vs AA, AG + GG vs AA, due to the presence of heterogeneity (all heterogeneity tests, I 2 .50%), whereas a fixed-effect model was used for others. No significant difference was observed for any genetic models (Table 2 , test of association, all P.0.05). The data failed to provide strong evidence regarding the association between the rs937283 and rs3730485 polymorphisms of MDM2 and overall SCC susceptibility.
MDM2/TP53 mutations and scc susceptibility
The MDM2 rs2279744 polymorphism has been reported to suppress the p53 pathway via the modulation of MDM2 expression. 2, 49 We also investigated the genetic relationship between SCC risks and MDM2/TP53 mutations, including MDM2 + /TP53 -, MDM2 -/TP53 + , and MDM2 + /TP53 + . Specific genotype information is shown in Table 5 . A random-effect model was used. The data in Table 5 
Publication bias and sensitivity analysis
The results of Begg's funnel plots and Egger's publicationbias plots demonstrated that the occurrence of large publication bias was excluded under all genetic models (Tables 2 and 4 Figure 6B ) models of MDM2 rs2279744 polymorphism are shown. With regard to the sensitivity analysis, compared with overall meta-analysis data, no significant difference for the pooled OR value was observed when each study was omitted sequentially ( Figure 2C for allele model of MDM2 rs2279744; Figure 3C for homozygote model; Figure 4C for heterozygote model; Figure 5C for dominant model; Figure 6C model; data not shown for others). Consequently, these data suggested that our statistical results were credible.
Discussion
More and more studies on the possible role of the MDM2 rs2279744 polymorphism in the onset and development of cancer have been reported. Hu et al performed a meta-analysis based on 25 published case-control studies, and reported that MDM2 rs2279744 seems to be associated with tumor susceptibility. 50 Chen et al reported that the MDM2 rs2279744 polymorphism may be linked to an increased digestive tract cancer risk in the Asian population. Here, we further focused on the potential effect of MDM2 rs2279744 in susceptibility to overall SCC and specific SCC types, including HNSCC, SSCC, ESCC, OSCC, CSCC, and LSCC.
Several SCC-related meta-analyses have been carried out previously. A meta-analysis by Liu et al based on seven articles with 1,629 cases and 2,472 controls showed that the G allele of the MDM2 rs2279744 polymorphism seemed to act as an important HNSCC protective factor in the Caucasian population, but not the Asian population. 26 However, in our meta-analysis, we were unable to observe a significant association between HNSCC susceptibility and MDM2 Alhopuro et al 31 Almquist et al 4 Cao et al 43 Chen et al 13 Er et al 30 Hamid et al 25 Hong et al 33 Huang et al 40 Jiang et al 39 Kohno et al 44 Li et al 46 Liu et al 34 Ma et al 42 Misra et al 18 Nakashima et al 37 Nan et al 47 Park et al 36 Roszak et al 32 Singhal et al 45 Tu et al 35 Yu et al 41 Zhang et al 12 Zhang et al 48 
Meta-analysis estimates, given named study is omitted
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Alhopuro et al 31 Almquist et al 4 Cao et al 43 Chen et al 13 Er et al 30 Hamid et al 25 Hong et al 33 Huang et al 40 Jiang et al 39 Kohno et al 44 Li et al 46 Liu et al 34 Loginov et al 38 Ma et al 42 Misra et al 18 Nakashima et al 37 Nan et al 47 Park et al 36 Roszak et al 32 Singhal et al 45 Tu et al 35 Yu et al 41 Zhang et al 12 Zhang et al 48 Zhou rs2279744. How to explain this? Seven studies were enrolled in the meta-analysis of Liu et al. 13, 18, 25, 31, 33, 35, 37 Also, data for OSCC in five studies 13, 18, 25, 33, 35 were included as HNSCC. The disease in two studies 31, 37 was defined only as HNSCC. In our subgroup analysis, we tested the relationship between OSCC risk and MDM2 rs2279744. One new study 41 was added in the new meta-analysis for HNSCC. We found that the MDM2 rs2279744 polymorphism did not appear to be associated with OSCC susceptibility, which is partly consistent with the results of Xie et al. 27 OncoTargets and Therapy 2016:9 submit your manuscript | www.dovepress.com
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MDM2 polymorphisms and scc susceptibility A meta-analysis by Chen et al based on six case-control studies, including 1,899 cases and 3,016 controls, showed that the MDM2 rs2279744 polymorphism may be associated with increased risks of overall esophageal cancer, including SCC and adenocarcinoma, especially in the Asian population. 28 However, our meta-analysis only targeted the ESCCs. We thus removed one study on esophageal adenocarcinoma 52 and added another new published case-control study. 12 All cases in six case-control studies were Chinese patients, with a mean age of .50 years and male:female ratio of .50%. The Alhopuro et al 31 Almquist et al 4 Cao et al 43 Chen et al 13 Er et al 30 Hamid et al 25 Hong et al 33 Huang et al 40 Jiang et al 39 Kohno et al 44 Li et al 46 Liu et al 34 Ma et al 42 Misra et al 18 Nakashima et al 37 Nan et al 47 Park et al 36 Roszak et al 32 Singhal et al 45 Tu et al 35 Yu et al 41 Zhang et al 12 Zhang et al 48 
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Alhopuro et al 31 Almquist et al 4 Cao et al 43 Chen et al 13 Er et al 30 Hamid et al 25 Hong et al 33 Huang et al 40 Jiang et al 39 Kohno et al 44 Li et al 46 Liu et al 34 Ma et al 42 Misra et al 18 Nakashima et al 37 Nan et al 47 Park et al 36 Roszak et al 32 Singhal et al 45 Tu et al 35 Yu et al 41 Zhang et al 12 Zhang et al 48 Zhou et al 24 Loginov GG genotype of MDM2 rs2279744 was likely to confer an increased susceptibility to ESCC in elderly male patients in People's Republic of China. The influence of habits and customs, such as drinking or smoking, should be considered.
Considering the close association between MDM2 and p53, [2] [3] [4] [5] it is meaningful to investigate the role of gene-gene interaction between MDM2 and TP53 Arg72Pro polymorphism in SCC risks. In our meta-analysis, we observed a positive association between MDM2 + /TP53 + double mutation and SCC susceptibility in overall or Asian populations. The underlying molecular mechanism on the effect of MDM2 genetic variation in the incidence of ESCC remains unclear. The rs2279744 SNP within the promoter region of MDM2 can lead to a T-G substitution at the 309 nucleotide site, which is closely linked to the high expression of the MDM2 protein via higher binding affinity with the transcriptional activator SP1, and thus enhances the degradation of p53. 2 It was possible that MDM2 rs2279744 polymorphism is linked to the increased SCC risks, through influencing the role of p53 pathway in genomic stability and tumor prevention. Chen et al conducted a meta-analysis to investigate the relationship between positive MDM2 expression and clinicopathological characteristics of ESCC, and found that high MDM2 expression was associated with early primary tumor stage and increased risk of regional lymph node metastasis, but not the risk of distant metastasis. 53 Vlatković et al reported that loss of MTBP expression seems to be associated with reduced survival in some patients with HNSCC. 54 In addition, several reported studies have estimated the role of the interaction between the MDM2/TP53 gene and several environmental factors, including smoking exposure, alcohol consumption, or human papillomavirus infections in SCC susceptibility. 13 with the occurrence of OSCC patients with HPV16 L1 seropositivity. 13 However, due to the lack of sufficient data, we failed to carry out a subgroup analysis based on these environmental factors.
Our meta-analysis contained several limitations. Very few publications resulted in small sample sizes for the analysis of MDM2 rs937283 and rs3730485. The possible effect of other unpublished studies on our negative conclusion should be taken into consideration. The same limitation of sample size existed in the meta-analysis of MDM2/ TP53 double mutation and several subgroup analyses of the MDM2 rs2279744 polymorphism. Heterogeneity and potential publication bias may weaken our conclusion. Demographic features, lifestyle, or clinical characteristics were not considered, due to the lack of data. Larger and independent studies are required to validate the association between MDM2/TP53 mutations and susceptibility to different types of SCC.
Conclusion
Our updated meta-analysis demonstrated that there is a positive association between increased overall SCC risks and the MDM2 rs2279744 polymorphism, rather than rs937283 or rs3730485. We further provided evidence that the GG genotype of MDM2 rs2279744 is more likely to confer an increased genetic susceptibility to ESCC in the Asian population, particularly in Chinese. MDM2 rs2279744 may be a valuable risk factor or diagnostic biomarker for patients with ESCC in People's Republic of China, and needs more supporting evidence.
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